重药控股

- 000950

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
重药控股(000950) 利润表
单位:万元
报表日期2024-09-302024-06-302024-03-312023-12-312023-09-30
一、营业总收入5,969,265.803,977,922.771,962,428.298,011,910.735,838,374.03
营业收入5,969,265.803,977,922.771,962,428.298,011,910.735,838,374.03
二、营业总成本5,905,843.433,927,194.851,938,457.747,903,158.025,746,574.30
营业成本5,525,437.223,668,862.401,810,347.017,381,039.265,362,368.76
营业税金及附加14,187.8910,081.214,294.1921,885.8814,810.47
销售费用170,832.16113,061.9355,693.53221,346.86164,702.78
管理费用113,147.5079,973.6142,319.71148,644.85105,834.86
财务费用81,381.0454,510.6225,783.37130,202.8498,508.18
研发费用857.62705.0719.9438.33349.26
资产减值损失----------
公允价值变动收益704.75890.59961.761,616.2380.23
投资收益24,191.9116,390.058,671.9330,154.7720,265.49
其中:对联营企业和合营企业的投资收益24,369.5416,335.118,671.9329,145.3620,039.76
汇兑收益----------
三、营业利润54,806.9544,252.6117,313.38100,709.4878,804.88
加:营业外收入2,011.731,382.07308.743,277.612,562.61
减:营业外支出2,110.541,025.46148.483,133.021,894.18
其中:非流动资产处置损失----------
四、利润总额54,708.1444,609.2217,473.64100,854.0779,473.31
减:所得税费用14,023.7610,338.683,997.3523,604.1617,145.13
五、净利润40,684.3734,270.5413,476.2977,249.9162,328.18
归属于母公司所有者的净利润29,222.5623,808.8610,296.0865,495.6951,761.45
少数股东损益11,461.8110,461.693,180.2211,754.2210,566.73
六、每股收益
基本每股收益(元/股)0.17000.14000.06000.38000.3000
稀释每股收益(元/股)0.17000.14000.06000.38000.3000
七、其他综合收益-26.91-65.24---4,147.9952.80
八、综合收益总额40,657.4634,205.3013,476.2973,101.9262,380.99
归属于母公司所有者的综合收益总额29,199.8323,753.7610,296.0861,392.6951,814.23
归属于少数股东的综合收益总额11,457.6310,451.543,180.2211,709.2310,566.76
下载全部历史数据到excel中 返回页顶